Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Konstantin Dergilev"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 18, p 10097 (2024)
The increasing burden of vascular dysfunction on healthcare systems worldwide results in higher morbidity and mortality rates across pathologies, including cardiovascular diseases. Vasculopathy is suggested to be caused by the dysregulation of vascul
Externí odkaz:
https://doaj.org/article/9809aa8158ad4b65a918e35a50e259ab
Autor:
Ekaterina Zubkova, Konstantin Dergilev, Irina Beloglazova, Alexander Kalinin, Alika Guseva, Alexander Andreev, Stanislav Partigulov, Mikhail Lepilin, Mikhail Menshikov, Yelena Parfyonova
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17278 (2023)
Cardiosphere-derived cells (CDCs) are currently being evaluated in clinical trials as a potential therapeutic tool for regenerative medicine. The effectiveness of transplanted CDCs is largely attributed to their ability to release beneficial soluble
Externí odkaz:
https://doaj.org/article/6d5c0d6bf7364080965c69b436e76adf
Autor:
Konstantin Dergilev, Ekaterina Zubkova, Alika Guseva, Zoya Tsokolaeva, Yulia Goltseva, Irina Beloglazova, Elizaveta Ratner, Alexander Andreev, Stanislav Partigulov, Mikhail Lepilin, Mikhail Menshikov, Yelena Parfyonova
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 23, p 16575 (2023)
Ischemic heart disease and its complications, such as myocardial infarction and heart failure, are the leading causes of death in modern society. The adult heart innately lacks the capacity to regenerate the damaged myocardium after ischemic injury.
Externí odkaz:
https://doaj.org/article/95e1d4e463214edbad70b20689122ee6
Autor:
Konstantin Dergilev, Zoya Tsokolaeva, Yulia Goltseva, Irina Beloglazova, Elizaveta Ratner, Yelena Parfyonova
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15554 (2023)
One of the largest challenges to the implementation of cardiac cell therapy is identifying selective reparative targets to enhance stem/progenitor cell therapeutic efficacy. In this work, we hypothesized that such a target could be an urokinase-type
Externí odkaz:
https://doaj.org/article/321055b4fb3645f28df001afbd2b841d
Publikováno v:
Cells, Vol 11, Iss 20, p 3278 (2022)
A Matrigel-based tube formation assay is a simple and widely accepted 2D angiogenesis model in vitro. Extracellular matrix (EM) proteins and growth factors (GFs) from MatrigelTM exclusively trigger endothelial cell (EC) tubular network (ETN) formatio
Externí odkaz:
https://doaj.org/article/4e9468ef4a064f79892c1161cfc224a8